insights_auto
Why is ARX up 3,03%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
0,51 A$
arrow_upward
+3,03%(+0,015) 1D
6 հոկ, 10:00:52 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,51 A$
High
0,51 A$
Low
0,51 A$
Mkt. cap
176,41 մլն
Avg. vol.
173,54 հզր
Volume
6,08 հզր
P/E ratio
48,99
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
Open
0,51 A$
High
0,51 A$
Low
0,51 A$
Mkt. cap
176,41 մլն
Avg. vol.
173,54 հզր
Volume
6,08 հզր
P/E ratio
48,99
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
News stories
From web sources and news partners
24/7 Wall St.
·
20 րոպե առաջ
Forget JEPQ: Goldman's Nasdaq Income Fund Raised Its October Payout While JPMorgan Cut Its Own
Yahoo Finance
·
23 րոպե առաջ
Goldman Sachs spills the beans on what’s next for S&P 500
TheStreet Pro
·
37 րոպե առաջ
Stocks Shrug Off New Highs in Yields as the Advance Broadens
Reuters
·
1 ժամ առաջ
Trading Day: Nasdaq highs, Brazil surprise
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd